Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
Authors
Keywords
-
Journal
NATURE IMMUNOLOGY
Volume 18, Issue 1, Pages 74-85
Publisher
Springer Nature
Online
2016-11-29
DOI
10.1038/ni.3632
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity
- (2015) Jellert T. Gaublomme et al. CELL
- Transcriptional Regulation of Mononuclear Phagocyte Development
- (2015) Roxane Tussiwand et al. Frontiers in Immunology
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Inhibition of IL-6 family cytokines by SOCS3
- (2014) Jeffrey J. Babon et al. SEMINARS IN IMMUNOLOGY
- Minimal Interleukin 6 (IL-6) Receptor Stalk Composition for IL-6 Receptor Shedding and IL-6 Classic Signaling
- (2013) Paul Baran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior
- (2012) Albert Quintana et al. BRAIN BEHAVIOR AND IMMUNITY
- IL-23: One cytokine in control of autoimmunity
- (2012) Andrew L. Croxford et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Cytokines Interleukin 27 and Interferon-γ Promote Distinct Treg Cell Populations Required to Limit Infection-Induced Pathology
- (2012) Aisling O’Hara Hall et al. IMMUNITY
- Induction and molecular signature of pathogenic TH17 cells
- (2012) Youjin Lee et al. NATURE IMMUNOLOGY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Notch2 Receptor Signaling Controls Functional Differentiation of Dendritic Cells in the Spleen and Intestine
- (2011) Kanako L. Lewis et al. IMMUNITY
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice
- (2011) Jin Hee Kim et al. PLoS One
- Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
- (2010) F. Thomas Wunderlich et al. Cell Metabolism
- The Transcription Factor GATA3 Actively Represses RUNX3 Protein-Regulated Production of Interferon-γ
- (2010) Ryoji Yagi et al. IMMUNITY
- Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
- (2010) Lydia Durant et al. IMMUNITY
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
- (2009) Amit Awasthi et al. JOURNAL OF IMMUNOLOGY
- IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier
- (2008) Ralf A. Linker et al. JOURNAL OF NEUROIMMUNOLOGY
- IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells
- (2008) Valérie Dardalhon et al. NATURE IMMUNOLOGY
- IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
- (2008) Satoshi Serada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells
- (2008) T. Korn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started